Objective Corticotrophin (ACTH)-induced hypertension in the rat is prevente
d by L- but not D-arginine. We examined the effects of exogenous corticoste
rone in the male Sprague Dawley (SD) rat to determine whether ACTH-induced
hypertension is mediated by corticosterone,
Methods Exogenous corticosterone (10, 20 or 40 mg/kg per day) or sham (poly
ethylene glycol (PEG) 1 ml/kg per day) was injected subcutaneously in divid
ed doses (s/c b.d.) over 15 treatment days to 40 SD rats (n = 10 each group
). Subsequently, the effects of L-arginine, D-arginine or L-arginine + N-ni
tro-L-arginine (NOLA) on corticosterone-induced hypertension (corticosteron
e 20 mg/kg per day) were examined. Systolic blood pressure (SBP) and metabo
lic parameters were measured every two days.
Results Twenty and 40 mg/kg per day of corticosterone increased SEP compare
d with sham (P < 0.01, P < 0.05 respectively, sham versus respective group)
. Forty mg/kg per day of corticosterone raised serum corticosterone concent
ration compared with sham (502 +/- 20 versus 364 +/- 25 ng/ml, P < 0.001).
L-arginine prevented the rise in SEP produced by corticosterone (131 +/- 3
to 131 +/- 2 mmHg, control versus day 10) but D-arginine did not (129 +/- 3
to 142 +/- 4 mmHg on day 8, P < 0.01). NOLA blocked the effect of L-argini
ne and amplified the rise in blood pressure produced by corticosterone (130
+/- 3 to 171 +/- 6 mmHg on day 10, P < 0.001).
Conclusions The haemodynamic features of ACTH-induced hypertension were rep
roduced by corticosterone excess, at concentrations of corticosterone simil
ar to those in studies of exogenous ACTH administration. It is likely that
ACTH-stimulated adrenal production of corticosterone accounts for the featu
res of ACTH-induced hypertension in the rat (C) 2000 Lippincott Williams &
Wilkins.